Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermal delivery system for sufentanil

Transdermal delivery system for sufentanil

US Patent 8252319 · Granted Aug 28, 2012

Estimated economic value: $559,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oral dosage form with drug composition, barrier layer and drug layer2025
Uses of oxygenated cholesterol sulfates (OCS)2023
Pharmaceutically active agent complexes, polymer complexes, and compositions and2022
Pharmaceutically active agent complexes, polymer complexes, and compositions and2022
Uses of oxygenated cholesterol sulfates (OCS)2020
Pharmaceutically active agent complexes, polymer complexes, and compositions and2020
Pharmaceutically active agent complexes, polymer complexes, and compositions and2020
Transoral dosage forms comprising sufentanil2020
Compositions with a rheological modifier to reduce dissolution variability2019
Uses of oxygenated cholesterol sulfates (OCS)2019
Oral pharamaceutical dosage forms2019
Depot formulations2018